Follow
Manfred Mitterer
Manfred Mitterer
Head Oncology Hematology Franz Tappeiner Hospital
Verified email at sabes.it
Title
Cited by
Cited by
Year
High expression of TROP2 correlates with poor prognosis in pancreatic cancer
D Fong, P Moser, C Krammel, JM Gostner, R Margreiter, M Mitterer, ...
British journal of cancer 99 (8), 1290-1295, 2008
2412008
Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study
J Willeit, S Kiechl, F Oberhollenzer, G Rungger, G Egger, E Bonora, ...
Arteriosclerosis, thrombosis, and vascular biology 20 (2), 529-537, 2000
2152000
Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab
U De Giorgi, G Procopio, D Giannarelli, R Sabbatini, A Bearz, S Buti, ...
Clinical Cancer Research 25 (13), 3839-3846, 2019
1742019
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
MH Kropff, N Lang, G Bisping, N Dominé, G Innig, M Hentrich, M Mitterer, ...
British journal of haematology 122 (4), 607-616, 2003
1712003
Procalcitonin‐reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients
M Svaldi, J Hirber, AI Lanthaler, O Mayr, S Faes, E Peer, M Mitterer
British journal of haematology 115 (1), 53-57, 2001
1182001
Mutations in DYT1 Extension of the phenotypic and mutational spectrum
K Kabakci, K Hedrich, JC Leung, M Mitterer, P Vieregge, R Lencer, ...
Neurology 62 (3), 395-400, 2004
1002004
Expression of 7F7‐antigen, a human adhesion molecule identical to intercellular adhesion molecule‐1 (ICAM‐1) in human carcinomas and their stromal fibroblasts
W Vogetseder, H Feichtinger, TF Schulz, W Schwaeble, P Tabaczewski, ...
International journal of cancer 43 (5), 768-773, 1989
941989
Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels
I Pichler, C Minelli, S Sanna, T Tanaka, C Schwienbacher, S Naitza, ...
Human molecular genetics 20 (6), 1232-1240, 2011
902011
Italian nivolumab expanded access program in nonsquamous non–small cell lung cancer patients: results in never-smokers and EGFR-mutant patients
MC Garassino, AJ Gelibter, F Grossi, R Chiari, HS Parra, S Cascinu, ...
Journal of Thoracic Oncology 13 (8), 1146-1155, 2018
852018
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease
S Kiechl, A Muigg, P Santer, M Mitterer, G Egger, M Oberhollenzer, ...
Circulation 99 (5), 614-619, 1999
781999
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme
U De Giorgi, G Cartenì, D Giannarelli, U Basso, L Galli, E Cortesi, ...
BJU international 123 (1), 98-105, 2019
762019
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients
M Ladetto, S Sametti, JW Donovan, D Ferrero, M Astolfi, M Mitterer, ...
Experimental Hematology 29 (2), 183-193, 2001
752001
Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations
MJ Mair, JM Berger, AS Berghoff, AM Starzer, G Ortmayr, HC Puhr, ...
JAMA oncology 8 (1), 106-113, 2022
602022
A web-and app-based connected care solution for COVID-19 in-and outpatient care: qualitative study and application development
T Schinköthe, MR Gabri, M Mitterer, P Gouveia, V Heinemann, N Harbeck, ...
JMIR public health and surveillance 6 (2), e19033, 2020
562020
Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer
D Fong, G Spizzo, M Mitterer, A Seeber, M Steurer, G Gastl, I Brosch, ...
Annals of surgical oncology 19, 4330-4336, 2012
532012
Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers
N Brüggemann, M Mitterer, AJ Lanthaler, A Djarmati, J Hagenah, ...
Parkinsonism & related disorders 15 (6), 425-429, 2009
522009
Determination of soluble CD21 as a parameter of B cell activation
HP Huemer, C Larcher, WM Prodinger, AL Petzer, M Mitterer, N Falser
Clinical & Experimental Immunology 93 (2), 195-199, 1993
491993
T‐cell receptor excision circles: a novel prognostic parameter for the outcome of transplantation in multiple myeloma patients
M Svaldi, AJ Lanthaler, M Dugas, P Lohse, N Pescosta, C Straka, ...
British journal of haematology 122 (5), 795-801, 2003
472003
Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis
M Mitterer, N Pescosta, F Fend, C Larcher, N Prang, F Schwarzmann, ...
British journal of haematology 90 (3), 526-531, 1995
441995
Identification and characterization of a novel membrane activation antigen with wide cellular distribution
TF Schulz, M Mitterer, W Vogetseder, G Böck, BL Myones, MP Dierich
European journal of immunology 18 (1), 7-11, 1988
441988
The system can't perform the operation now. Try again later.
Articles 1–20